tryptophylglycine has been researched along with glycylsarcosine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Faria, TN; Quan, Y; Smith, RL; Stouch, TR; Timoszyk, JK; Vig, BS; Wall, DA | 1 |
Enomoto, S; Kano, T; Kobayashi, S; Morimoto, K; Ogihara, T; Shirasaka, Y; Tamai, I; Wada, S; Wagatsuma, T; Yabuuchi, H | 1 |
2 other study(ies) available for tryptophylglycine and glycylsarcosine
Article | Year |
---|---|
Human PEPT1 pharmacophore distinguishes between dipeptide transport and binding.
Topics: Animals; Binding Sites; Biological Transport; Cell Line; Dipeptides; Dogs; Electricity; Hydrophobic and Hydrophilic Interactions; Models, Molecular; Peptide Transporter 1; Proline; Protein Binding; Protein Conformation; Structure-Activity Relationship; Symporters | 2006 |
Oseltamivir (tamiflu) is a substrate of peptide transporter 1.
Topics: Administration, Oral; Animals; Animals, Newborn; Antiviral Agents; Biological Transport; Brain; Caco-2 Cells; Caseins; Dipeptides; Female; Food-Drug Interactions; HeLa Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Male; Milk; Oseltamivir; Peptide Transporter 1; Rats; Rats, Wistar; Symporters; Temperature; Transfection | 2009 |